Theratechnologies (THTX) Financials

$3.39

$0.00 (0.00%)

As on 02-Oct-2025 09:30EDT

Market cap

$156 Mln

Revenue (TTM)

$84 Mln

P/E Ratio

--

P/B Ratio

20.1

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Nov-24	Nov-23	Nov-22	Nov-21	Nov-20	Nov-19	Nov-18	Nov-17	Nov-16	Nov-15
Cash From Operating Activities	--	2.38	-5.68	-14.69	-14.48	-13.55
Cash Flow from Investing Activities	--	0.94	1.11	8.68	-12.45	4.78
Cash from Financing Activities	--	-21.49	14.78	9.66	34.56	-7.23
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Nov-24	Nov-23	Nov-22	Nov-21	Nov-20	Nov-19	Nov-18	Nov-17	Nov-16	Nov-15
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Nov-24	Nov-23	Nov-22	Nov-21	Nov-20	Nov-19	Nov-18	Nov-17	Nov-16	Nov-15
ROCE (%)	--	-28.43	-58.26	-79.63	-47.67	-28.46
ROE (%)	--	36.00	110.30	1,963.71	-302.37	-161.57
ROA (%)	-8.61	-12.67	-28.02	-44.46	-28.93	-20.82
EBIT Margin (%)	0.22	4.80	-14.95	-50.34	-37.23	-26.17
Net Margin (%)	-10.85	-9.67	-29.30	-59.00	-45.44	-34.32
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Nov-24	Nov-23	Nov-22	Nov-21	Nov-20	Nov-19	Nov-18	Nov-17	Nov-16	Nov-15
Revenue Growth (%)	2.19	0.05	0.02	0.15	0.06	0.04
EBIT Growth (%)	-89.40	133.70	69.67	-55.00	-50.37	-130.34
Net Profit Growth (%)	-30.91	65.33	49.28	-48.90	-39.96	-81.39
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Nov-24	Nov-23	Nov-22	Nov-21	Nov-20	Nov-19	Nov-18	Nov-17	Nov-16	Nov-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	20.13	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	74.63	5.23	-2.09	-1.21	-0.95	-3.95
Close Price ($)	2.65	1.21	1.58	8.52	13.20	9.20
High Price ($)	3.13	2.58	8.78	13.48	17.84	13.28
Low Price ($)	1.12	1.08	0.88	6.96	8.36	5.32
Market Cap ($ Cr)	155.87	--	--	--	--	--

Solvency Ratios	TTM	Nov-24	Nov-23	Nov-22	Nov-21	Nov-20	Nov-19	Nov-18	Nov-17	Nov-16	Nov-15
Debt to Equity	-1.41	-1.80	-2.83	-2.96	3.20	17.18
Short term debt to equity ratio	-0.13	-0.15	-0.37	-2.89	0.03	0.13
Current Ratio	0.84	1.19	1.34	0.64	2.04	1.55
Quick Ratio	0.65	1.05	1.21	0.47	1.39	0.95
Interest Coverage	0.07	0.40	-1.16	-6.20	-4.59	-3.22

Operating Efficiency Ratios	TTM	Nov-24	Nov-23	Nov-22	Nov-21	Nov-20	Nov-19	Nov-18	Nov-17	Nov-16	Nov-15
Debtors to sales (%)	13.48	18.17	16.57	13.31	13.26	16.57
Asset Turnover	0.79	1.31	0.96	0.75	0.64	0.61
Receivable days	--	62.01	54.07	45.44	52.85	58.24
Inventory Days	--	101.34	239.54	339.34	426.22	312.77
Payable days	--	118.93	184.87	197.45	259.38	207.84
Cash Conversion Cycle	--	44.42	108.75	187.33	219.70	163.17

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.